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Finishing the euchromatic sequence of
the human genome
International Human Genome Sequencing Consortium*
* A list of authors and their affiliations appears in the Supplementary Information
...........................................................................................................................................................................................................................
The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about
human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic
portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence
with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome
sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers,99% of the euchromatic genome and
is accurate to an error rate of,1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental
duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly
improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the
human genome seems to encode only 20,000–25,000 protein-coding genes. The genome sequence reported here should serve as a
firm foundation for biomedical research in the decades ahead.
The Human Genome Project (HGP) was launched in 1990 with the
goal of obtaining a highly accurate sequence of the vast majority of
the euchromatic portion of the human genome. The initial work
followed a two-pronged approach: (1) the mapping of the human
and mouse genomes1–9 to allow the study of inherited disease and
provide a crucial scaffold for genome assembly; and (2) the
sequencing of organisms with smaller, simpler genomes10–14 to
serve as a testbed for method development and assist in interpreting
the human genome. With success along both paths, the sequencing
of the human genome itself eventually became feasible. The Inter-
national Human Genome Sequencing Consortium (IHGSC), an
open collaboration involving twenty centres in six countries, was
formed to carry out this component of the HGP.
In February 2001, the IHGSC15 and Celera Genomics16 each
reported draft sequences providing a first overall view of the
human genome. These sequences allowed systematic study of the
human genome itself, including identification of genes, combina-
torial architecture of proteins, regional differences in genome
composition, distribution and history of transposable elements,
distribution of polymorphism and relationship between genetic
recombination and physical distance. Moreover, systematic knowl-
edge of the human genome has enabled new tools and approaches
that have markedly accelerated biomedical research.
Both draft sequences, however, had important shortcomings. The
IHGSC sequence, for example, omitted ,10% of the euchromatic
genome; it was interrupted by ,150,000 gaps; and the order and
orientation of many segments within local regions had not been
established. The IHGSC thus turned to the challenge of completing
the sequence of the euchromatic genome. Operationally, a finished
sequence was defined as having an error rate of, at most, one event
per 104 bases, and the goal for completion was coverage in finished
sequence of at least 95% of the euchromatic genome, with the only
gaps being those refractory to all available techniques17 (see http://
www.genome.gov/10000923). The goal was challenging because the
human genome is replete with such features as dispersed repeats and
large segmental duplications, which greatly complicate the deter-
mination of genome structure and sequence. In fact, near-complete
sequences have been obtained so far only for three multicellular
organisms: the nematode13, mustard weed18 and the fruitfly19. These
genomes are all roughly 30-fold smaller than the human genome
and have much simpler structure.
We describe here the results of a multiyear effort by the IHGSC
towards the goal of a complete human sequence. The number of
gaps has been reduced 400-fold to only 341, most of which are
associated with segmental duplications and will require new
methods for resolution. The assembled near-complete genome
sequence has an error rate of only ,1 event per 100,000 bases; it
contains 2.85 billion nucleotides and covers ,99% of the euchro-
matic genome. This paper describes the current genome sequence
and the process used to produce it; examines the accuracy and
completeness of the sequence; and illustrates biological analyses
made possible by the sequence. We do not attempt here a compre-
hensive analysis of the contents of the human genome. An initial
analysis was previously reported15 and a series of papers is being
written describing the individual chromosomes17,20–30, including
annotation of genes and other features.
Current genome sequence
Finishing process
The process of converting the initial draft sequence into a near-
complete sequence is referred to as ‘finishing’. It is a complex
iterative process that proceeds simultaneously at multiple scales,
ranging from single nucleotides to the integrity of whole chromo-
somes. The fundamental challenge is that genomic regions that are
not well represented or readily resolved through random shotgun
sequencing tend to be highly enriched in problematic sequences.
Resolving such regions required the development of special
approaches, which evolved substantially over time and varied
among centres.
Broadly, the finishing process involved two distinct components:
(1) producing finished maps, consisting of continuous and accurate
paths of overlapping large-insert clones spanning the euchromatic
region of each chromosome arm; and (2) producing finished clones,
consisting of continuous and accurate nucleotide sequence across
each large-insert clone. In practice, these two components were
tightly intertwined in that progress in each often depended on
results from the other. The components are described in Boxes 1 and
2. Further information about the finishing process and finishing
standards can be found in the Supplementary Information (Note 1)
and at http://www.genome.gov/10000923.
In total, we generated a shotgun sequence from 59,208 large-
insert clones (total length ,5.84 gigabases (Gb)) and finished the
sequence from 45,742 of these clones (total length ,3.67 Gb). The
clones consisted primarily of bacterial artificial chromosomes
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(BACs), but also included some P1-artificial chromosomes (PACs),
yeast artificial chromosomes (YACs), fosmids and cosmids; they
carried DNA from multiple anonymous sources15. We then chose a
‘clone tiling path’ of 26,720 overlapping clones across the genome,
selected a ‘sequence tiling path’ of directly adjacent, non-overlapping
segments from consecutive clones and concatenated these segments
to create a near-complete genome sequence. Contributions of the
IHGSC centres to this finishing phase are shown in Table 1.
Genome sequence
The human sequence reported here consists of 2,851,330,913
nucleotides, lying almost entirely within the euchromatic portion
of the genome (Table 2). It is interrupted by only 341 gaps, of which
33 gaps (totalling ,198 megabases (Mb)) reflect heterochromatin,
which was not targeted by the HGP, and 308 gaps (totalling
,28 Mb) are euchromatic. The euchromatic genome is thus
,2.88 Gb and the overall human genome is ,3.08 Gb. The long-
range continuity of the current genome sequence is high by various
measures (Table 3). The N50 length is 38.5 Mb and the N-average
length is 40.9 Mb; these values are ,1,000-fold larger than the size
of a typical human gene. (The first statistic is the length x such that
at least 50% of nucleotides lie in a continuous segment of length $x,
whereas the second is the average length of the contiguous segment
containing a randomly chosen nucleotide.) Focusing on individual
Box 1
Finishing the physical map
The hierarchical strategy used two kinds of genome maps as a
foundation for producing finished sequence: sequence-tagged site
(STS) maps6 and clone maps7. The first provided global landmarks by
positioning tens of thousands of STSs through genetic mapping,
radiation hybrid mapping and STS-content mapping. The second
provided overlapping clones for sequencing and was obtained by
comparing restriction-digest fingerprints of hundreds of thousands of
BAC clones to create local contigs. The two maps were integrated by
anchoring the contigs to the global landmarks.
The initial random phase generated a physical map covering 96–98%
of the euchromatic genome in ,1,000 anchored contigs separated by
gaps with average size of ,100 kb7. Overlapping clones were chosen
from this map to produce the draft sequence. The subsequent finishing
phase involved verifying clone overlaps and closing gaps in the initial
map. The finishing process for each chromosome was overseen by a
designated centre and managed by a dedicated coordinator, who
integrated and reviewed information from contributing centres.
Clone overlaps were verified by analysing finished sequence to
confirm that the terminal sequence overlapped for $2 kb with $99.6%
identity. (Perfect identity was not expected in all cases, because the
clones might derive from different haplotypes and thus differ at
polymorphic sites.) A small number of overlaps (n ¼ 308) falling below
this threshold were accepted, because the sequencing centre
presented additional evidence that the overlap was correct. For
example, smaller overlaps might be confirmed by a partially
sequenced clone spanning the overlap, or a region of high variation
might be shown to be due to allelic variation. All these exceptions are
recorded in electronic tags shown on the UCSC genome browser.
Remaining overlaps were rejected and counted as new gaps in the
map.
Closing gaps required identifying a tiling path of clones spanning the
region. Methods used are summarized in Box 1 Fig. 1. The primary
approach was iterative ‘walking’ from the ends of contigs: a stretch of
terminal sequence from a terminal clonewas used to identify a newclone
extending the contig. The procedure was repeated until it either yielded a
clone connecting to the neighbouring contig or reached a dead end.
Walking used both experimental (hybridization to arrayed BAC libraries)
and computational (comparison with a database of BAC end-
sequences) methods to identify candidate clones. Also, it was
sometimes possible to ‘parachute’ into gaps by identifying sequences
likely to lie within the gap (such as STSs, mRNAs and mouse sequences
in regions of conserved synteny) and using them as hybridization probes
for BACs.
Some gaps could not be closed, either because no new clone could
be found despite screening of diverse and deep libraries (.30-fold
physical coverage) or because a complex collection of clones was found
whose relationship proved impossible to discern owing to the presence
of extensive highly repetitive sequences or near-exact segmental
duplication. Telomeric regions of chromosomes were obtained by using
a specialized cloning system (‘half-YACs vectors’) in which successful
propagation required that the human insert DNA provided telomeric
function. By far, the most difficult regions of the genome were those
containing near-exact segmental duplications. A particularly challenging
example is shown in Box 1 Fig. 2.
Box 1 Figure 1 Simplified flowchart for finishing the physical map.
Box 1 Figure 2 Illustration of a challenging region on chromosome Y. a, The sequence
organization of the palindromic repeat P3 is represented by the horizontal bar at the base
of the triangle. Arrows indicate orientation of sequences in the 283-kb arms of the
palindrome (b1, t1 on left and t2, b2 on right). A non-repeated 170-kb ‘spacer’ (white)
separates the arms. Above the horizontal bar, each dot represents a perfect match of
500 bp. The near identity between the arms (99.94%) appears as a vertical line of dots,
highlighted by the blue diamond. b, Tiling path of BACs from RPCI-11 library. c, Sequence
differences, numbered 1–7, between arms of P3. Differences 3, 5, 6 and 7 are single
nucleotide differences, whereas 1, 2, and 4 are differences in the lengths of simple
tandem repeats (microsatellites); L, long variant; S, short variant. These differences
allowed assignment of BACs to the correct arm of P3.
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chromosome arms, the N50 length exceeds half the length of the
arm in three-quarters of cases (Table 3).
The sequence is denoted as NCBI Human Build 35 (May 2004),
with the individual chromosomes having accession numbers
NC000001 to NC000024 (see Supplementary Information Note 3
concerning additional sequence data). The analyses reported here
were performed on Build 35 or, in a few cases, its immediate
predecessor, Build 34 (which differed only slightly). The poster
accompanying this paper displays the 24 human chromosomes,
together with various biological annotations. These include GC
content, repeat content, segmental duplications, protein-coding
genes, sequence similarity and synteny conservation with mouse,
sequence similarity with the pufferfish, and density of single-nucleo-
tide polymorphisms in the human genome. Many additional anno-
tations can be found on public genome browsers (http://
genome.ucsc.edu/; http://www.ensembl.org/; http://www.ncbi.nlm.
nih.gov/genome/guide/human/), which are regularly updated.
Comparison with draft sequence
The near-complete sequence is a great improvement over the earlier
draft sequence. It has substantially fewer gaps (341 versus 147,821)
and greater continuity (38,500 kilobases (kb) versus 81 kb for N50
contig size), reflecting an overall improvement of ,475-fold. The
draft sequence contained regions in which the local order and
orientation were unknown; these have now been resolved. The
case of chromosome 7 is illustrated in Fig. 1. Additionally, the draft
sequence contained substantial artefactual duplication, including
local events caused by errors in merging some adjacent BAC-based
sequences, made by the first-generation global assembly program,
and global events caused by contamination of shotgun assemblies of
some BACs with data from other clones. These artefacts have now
been eliminated.
Accuracy and completeness
Because the human genome sequence is intended to serve as a
Table 1 Bases sequenced in Build 35

























Columns indicate total finished sequence deposited in public databases (including overlaps and
alternative alleles) and finished sequence incorporated into Build 35 (consisting of those clones
chosen for inclusion in the tiling path by the individual chromosome coordinators). The total includes
finished sequence completed at the time of the draft sequence15,17,20 and subsequently. Some
cloneswere sequenced to draft coverage by one centre, then finished by another. Abbreviations: SI,
Wellcome Trust Sanger Institute (Hinxton, UK); WUGSC, Washington University Genome Sequen-
cing Center (St Louis, USA); JGI, US Department of Energy Joint Genome Institute (Walnut Creek,
USA); WIBR, Whitehead Institute for Biomedical Research (Cambridge, USA); BCM, Baylor College
of Medicine Human Genome Sequencing Center (Houston, USA); RIKEN, RIKEN Genomic
Sciences Center (Yokohama, Japan); UWGC, University of Washington Genome Center (Seattle,
USA); GS, Genoscope (Evry, France); Keio, Keio University School of Medicine (Tokyo, Japan);
GTC, Genome Therapeutics Corporation (Waltham, USA); UWMSC, Institute for Systems Biology
Multimegabase Sequencing Center (Seattle, USA); IMB, Institute of Molecular Biology (Jena,
Germany); Beijing, Beijing Genomics Institute, Beijing, China); UOKNOR, University of Oklahoma’s
Advanced Center for Genome Technology (Norman, USA); SHGC, Stanford Human Genome
Center (Stanford, USA); MPIMG, Max Planck Institute for Molecular Genetics (Berlin, Germany);
GBF, GermanResearchCenter for Biotechnology (Braunschweig, Germany); TIGR, The Institute for
Genome Research (Rockville, USA); CGM, Center for Genetics in Medicine (Perkin Elmer/Washin-
ton Univ.); SDSTDC, Stanford DNA Sequencing and Technology Development Center (Stanford,
USA); UTSW, University of Texas, Southwestern Medical Center (Dallas, USA). ‘Other’ includes
clones from groups that deposited,1Mb of finished sequence that comprises Build 35. The total
includes 5,387bp, distributed across nine chromosomes, that were ambiguous (scored as ‘N’) and
therefore not counted in the total figure used in the text.
Table 2 Finished sequence and gaps, HGSC Build 35
Chr Total finished sequence* (kb) Euchromatic gaps† Heterochromatic gaps‡ Estimate of total gap size§ (kb) Unfinished clonesk
Number Est. size (kb) Number Est. size (kb) Number Est. size (kb)
...................................................................................................................................................................................................................................................................................................................................................................
1 222,828 32 1,605 2 19,510 21,115 17 850
2 237,503 20 2,512 1 2,900 5,412 0 0
3 194,636 5 1,935 1 1,500 3,435 0 0
4 187,161 14 1,250 1 3,000 4,250 0 0
5 177,703 5 92 1 340 432 0 0
6 167,318 10 658 1 2,300 2,958 0 0
7 154,759 11 869 1 4,630 5,499 0 0
8 142,613 9 662 1 2,190 2,852 0 0
9 117,781 40 1,955 2 18,000 19,955 12 600
10 131,614 12 1,020 1 2,515 3,535 8 400
11 131,131 7 322 1 4,760 5,082 0 0
12 130,259 8 795 1 4,300 5,095 0 0
13 95,560 6 715 2 17,200 17,915 0 0
14 88,291 1 8 2 17,220 17,228 0 0
15 81,342 10 737 2 18,260 18,997 0 0
16 78,885 4 143 2 10,000 10,143 0 0
17 77,800 9 875 1 7,500 8,375 0 0
18 74,656 3 97 1 1,368 1,465 0 0
19 55,786 5 5,015 1 340 5,355 0 0
20 59,505 4 1,157 1 1,766 2,923 0 0
21 34,170 3 53 2 11,620 11,673 0 0
22 34,765 11 460 2 14,330 14,790 0 0
X 150,394 12 750 1 3,000 3,750 14 700
Y 24,872 9 1,480 2 31,618 33,098 7 350
Total 2,851,331 250 25,165 33 200,167 225,332 58 2,900
...................................................................................................................................................................................................................................................................................................................................................................
*The total length of tiling paths including only finished bases of clones in Build 35. Roughly 2.19Mb of sequence on chromosome Y was derived directly from the equivalent pseudoautosomal region on
chromosome X.
†Defined as gaps in euchromatic regions, including junctions with heterochromatic/centromeric sequences, for which no clone was available (see text).
‡Defined here as gaps in heterochromatic regions (see text and Supplementary Note 2 on heterochromatic sequence). Separate gapswere counted for centromeres and pericentric heterochromatin, even
when the two were contiguous. Centromere sizes were taken from ref. 62 or in some cases provided directly by the sequencing centres (see Supplementary Note 2). Acrocentric sizes are based on
centromere ratios from ref. 63. The sizes of large heterochromatic gaps are typically difficult to estimate accurately owing to their repeat structure and polymorphic nature62,64. Other regions might arguably
be called heterochromatin (for example, the pericentric regions of chromosomes 19 and 3 and a ,400-kb gap on the Y chromosome23), but are classified as euchromatin here.
§The sum of lengths for finished sequence, estimated heterochromatic gaps, euchromatic gaps and unfinished clone gaps. The total length is only approximate because of uncertainty in gap sizes,
particularly for heterochromatic gaps and centromeres.
kThose in the tiling path but for which it has not been possible to obtain finished sequence. Unfinished sequence from these clones is deposited in public databases. These gaps are all listed at 50 kb,
reflecting the approximate average size of the gap.
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Box 2
Finishing the sequence of clones
Sequencing of large-insert clones began with production of an initial
assembly based on shotgun sequence data. For a typical BAC clone, we
generated 6–10-fold coverage in paired end-sequences from random,
small-insert (2–4 kb) plasmid clones and used computer programs (P.
Green, unpublished and see ref. 68) to assemble the data into sequence
contigs connected by linking information. Each base was assigned a
quality score reflecting its predicted accuracy, based on the underlying
shotgun sequence data. The assembly typically had gaps and low-
quality regions, with the number varying greatly across clones. These
regions are highly enriched in sequences that are difficult to clone or
sequence and thus are not represented even after deep (6–10-fold)
coverage with random reads. (These regions are also poorly covered by
whole-genome shotgun strategies69.)
The finishing phase converted this draft assembly into a high-quality
continuous sequence by obtaining directed information. It involved
iterative cycles of computational analysis and laboratory work. Box 2 Fig.
1 shows a simplified flowchart. The first step was to inspect the draft
assembly for evidence of mis-assembly, arising from inappropriate
merger of repeated sequences. Such evidence would include
inconsistent patterns of linking among contigs, regions with unusually
high coverage in sequence reads and bases with ‘high-quality
discrepancies’ among the underlying sequence reads. In general,
sequence assembly is more straightforward for the clone-based
hierarchical shotgun strategy than for the whole-genome shotgun
strategy, because the use of clones avoids problems arising from
polymorphism and from different copies of repeated regions elsewhere
in the genome. Most clones passed assembly inspection, but some
failed due to the presence of very similar local dispersed, tandem or
inverted repeats. Careful inspection could resolve the problem in some
cases, but specific strategies had to be devised in other cases. One
approach was to isolate distinct copies of the repeat in subclones of
intermediate size (10-kb plasmids or fosmids) and sequence these
subclones. Box 2 Fig. 2 illustrates an initially mis-assembled BAC clone
from chromosome Y that could be assembled correctly with careful
editing.
The second step was gap closure. Because gaps tended to be
enriched for problematic sequences, gap closure was challenging; it
often required multiple attempts using a variety of alternative methods.
Gaps were classified into two types: ‘spanned’ and ‘unspanned’.
Spanned gaps were those for which the two flanking contig ends were
linked by an end-sequenced plasmid. Most such gaps could be closed
by primer-directed sequencing of the plasmid, serially extending the
Box 2 Figure 1 Simplified flowchart for finishing of clones.
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contig sequence into the gap. Sequence in the gap was often
recalcitrant to the standard sequencing protocol (accounting for its
absence from the initial shotgun data), making it necessary to use many
alternative protocols (different buffers, enzymes and temperature
conditions). Some gaps could not be closed by primer walking, because
no suitable primer could be found (due to repetitive sequence near the
end of the contig) or because sequencing chemistries were unable to
penetrate certain secondary structures (such as some inverted repeats).
Specialized strategies were used to obtain the missing sequence. For
example, problems arising from secondary structuremight be overcome
by sequencing a small insert library70 of random subclones with tiny
inserts (,100–300bp, referred to as a “shatter library”) or by
sequencing from transposon insertions in the plasmid. Unspanned gaps
arose where a contig end was not linked to any other contig. It was then
necessary to infer adjacency and extend the sequence by other means.
Techniques included PCR to other contigs, analysis of various types of
subclones from the BAC, and primer walking directly on the BAC71. This
battery of techniques succeeded in virtually all cases. (In 728 cases,
there remains a small region of bases that could not be reliably
sequenced; almost all fall in tandem repeat sequences and typically
affect tens to hundreds of bases. These cases are annotated in the
accessioned clones.)
The third step (which proceeded in parallel to gap closure) was the
resolution of low-quality regions. This was accomplished by obtaining
additional sequence reads from resequencing of existing shotgun
subclones or from primer-directed sequencing.
The final step involved quality control. To confirm the accuracy of the
overall assembly, the restriction digestion pattern of the BAC predicted
from the finished sequence was compared with the pattern observed
experimentally. To confirm accuracy at the nucleotide level, the finished
sequence and supporting data were reviewed by human inspection and
computational analysis. The finished sequence was then annotated and
deposited in public databases.
Box 2 Figure 2 Illustration of a particularly challenging clone. a, Central portion of clone
RP11-488I11 is illustrated by a triangular dot plot. The base of the triangle represents
80 kb of a 152-kb insert. Each dot represents a perfect match of 20 bases. The region
between 65 kb and 94 kb contains four copies of a directly repeated sequence of about
3 kb (horizontal lines), separated by imperfect short tandemly repeated sequence
(diamond blocks of dots). The region between 94 kb and 107 kb contains tandemly
repeated imperfect copies of a five-base sequence, unrelated to the previous sequence.
b, Initial assembly of region after completion of shotgun data collection. Two mis-
assemblies resulting from the long direct repeats and the absence of all copies (not
shown) were resolved by manual editing, after which 12 gaps remained in the clone. Five
of these (labelled A) were spanned by plasmid subclones and were closed by primer
walking. Two gaps (labelled B) were larger; after initial walks failed, these gaps were
closed by sequencing short insert libraries prepared from PCR products. Four other gaps
(labelled C) were not spanned by plasmid clones but were closed by primer walks on PCR
products. One gap (labelled D) was closed by primer walks and extensive manual editing.
c, The finished clone with all gaps closed.
Figure 1 Comparison of previous draft sequence with current near-complete sequence of
chromosome 7 (ref. 24). At large scale, there was good collinearity between draft and
near-complete sequence, although some inversions were present in the draft due to lack
of sufficient anchors in some regions. At finer scale, the draft sequence contained some
sequence contigs for which order and orientation were not known. The inset shows a
region of 500 kb with sequence derived from three overlapping BACs. BACs at each end
were finished at the time of draft assembly, whereas the middle BAC was at an early stage
of shotgun coverage in which contigs were not yet ordered and oriented.
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permanent foundation for biomedical research, it was important to
assess its quality and to characterize its remaining defects. For this
purpose, we used a number of comparisons and consistency checks.
Assessment of accuracy
Tests of accuracy were designed to detect potential problems that
may have occurred in clone-based sequencing. This may include
errors in assembling the finished sequence within individual clones,
and errors in concatenating adjacent finished clones to create the
final product. The analysis was complicated by the presence of
polymorphism in the human population, because differences
between sequence clones may reflect either errors or polymorphism.
Independent quality assessment. Quality assessment (QA) exer-
cises were performed regularly throughout the HGP31. In the final
stages, an independent group examined a random sample of
finished clones by generating additional data and generating new
assemblies32. Briefly, this QA analysis examined ,34 Mb and found
an error rate of 1.1 per 100 kb for small events (#50 bp, with average
size of 1.3 bp) and 0.03 per 100 kb for large events (.50 bp). The
small events consisted largely of single-base substitutions, whereas
the remaining small and large events primarily concerned the
number of consecutive copies of a tandem repeat32.
Analysis of clone overlap. We extended the QA analysis to a larger
region (,174 Mb), by examining overlapping sequence between
consecutive finished large-insert clones. If two such clones derive
from the same copy of the human genome, any sequence differences
in the overlap must reflect an error in one of the two clones. By
comparing independent clones, this quality assessment method also
has the ability to detect cloning artefacts. We examined 4,356
substantially overlapping clones derived from the same library;
half are expected to be derived from the same haplotype and half
from a different haplotype. We counted the number of single-base
mismatches (ignoring insertion/deletions (indels)) in the overlap-
ping regions. The resulting distribution (Fig. 2a) is bimodal. The
first peak is consistent with expectation for clones from the same
haplotype, with a sequencing error rate of ,1025 per bp. The
second peak is consistent with the expectation for clones from
different haplotypes, with a polymorphism rate of ,1023 per bp;
this peak matches the distribution seen for clones from different
libraries.
We then examined overlapping clones likely to be from the same
haplotype (with no single-base mismatches) and counted the
discrepancy rate for indels (Fig. 2b). The error rate (estimated as
half the discrepancy rate) is ,0.55 events per 100 kb, with the vast
majority being in tandem repeats. By contrast, clones from different
libraries show a discrepancy rate that is at least 20-fold higher.
Overall, the analysis indicates that the overall error rate (reflecting
both sequence error and cloning artefacts) is 20–100-fold lower
than the human polymorphism rate.
Analysis of junctions. We assessed longer-range integrity of the
genome sequence by studying read pairs from large insert clones.
Specifically, we created a fosmid library carrying randomly sheared
human DNA and sequenced both ends of the insert of ,750,000
clones. Fosmid clones are particularly useful because their insert
sizes cluster tightly around 40 kb, due to packaging constraints. We
aligned the fosmid end sequences to the genome sequence. Both ends
could be mapped to unique locations in the human genome in most
cases (86%), and these two locations were within 39.5 ^ 7.5 kb in
99% of cases. Some fosmids could not be uniquely placed because
one or both ends consisted almost entirely of repeat sequence. Using
the uniquely placed fosmids (which provide about eightfold clone
coverage of the euchromatic genome), we sought to obtain inde-
pendent confirmation of the order, orientation and adjacency of
the junction between consecutive finished large-insert clones used
to construct the genome sequence. The junction was considered
‘supported’ if spanned by one or more consistently placed fosmids.
In all, ,97% of junctions were supported. About half of the
remaining junctions were supported by fosmids with unique
placement at one end but multiple placements at the other end.
Overall, the analysis provided strong support for accuracy of the
junctions underlying the current genome sequence.
Search for deletions. We next scanned the genome sequence for
evidence of deletions of several kilobases in size, using the same
fosmid data set. At each point, we calculated the ‘apparent size’ of
each fosmid spanning the point (defined as the distance between the
location of the end sequences in the current genome sequence) and
then calculated the ‘average apparent size’ for all the fosmids
spanning the point. We searched for regions where the observed
size fell far below expectation (,3.5 standard deviations (s.d.)),
suggesting a large difference between the genome sequence and the
source DNA for the fosmid library (Fig. 3). Such differences could
reflect either an error in the genome sequence, a deletion in the
fosmid clone, or a deletion polymorphism between the DNA
sources. (Given the number of fosmids used, this analysis has
,50% sensitivity to detect deletions of 3–30 kb. Because the
Table 3 Chromosome arm length and contiguity in draft and reference sequence
Build 35
Chromosome Euch. length* (bp) N50† draft§ (bp) N50 refk (bp) N-average ref§ (bp)
.............................................................................................................................................................................
1p 121,147,476 81,895 16,783,271 33,566,574
1q 104,135,370 45,843 56,331,646 36,675,159
2p 91,748,045 68,853 68,373,980 53,478,029
2q 148,270,183 50,481 84,213,156 54,482,973
3p 90,587,544 39,322 66,080,833 54,853,737
3q 106,018,194 35,734 100,530,261 96,935,077
4p 49,501,045 36,494 9,040,907 13,797,821
4q 138,910,172 31,876 92,070,735 66,386,026
5p 46,441,398 59,470 46,378,398 46,378,398
5q 131,416,467 81,416 41,199,371 33,564,217
6p 58,938,125 251,648 48,945,890 42,200,138
6q 109,037,573 150,424 61,695,806 46,408,435
7p 57,864,988 399,235 47,497,097 40,050,874
7q 97,763,150 298,612 64,426,257 46,810,648
8p 43,958,052 40,151 9,464,880 9,872,060
8q 99,316,773 37,528 57,155,273 47,945,192
9p 46,035,928 87,767 39,435,726 34,619,306
9q 74,393,339 43,983 40,394,264 29,078,785
10p 39,244,941 48,121 20,794,160 15,791,760
10q 93,788,686 47,401 30,112,613 31,833,318
11p 51,450,781 34,383 49,571,094 48,044,101
11q 80,001,602 42,527 17,911,127 26,070,918
12p 34,747,961 197,985 27,615,668 23,435,010
12q 96,306,849 47,272 32,815,934 29,605,325
13p acro arm n/a n/a n/a
13q 96,274,979 70,497 67,740,325 54,830,719
14p acro arm n/a n/a n/a
14q 88,298,584 1,370,997 88,290,585 88,290,585
15p acro arm n/a n/a n/a
15q 82,078,915 30,303 53,619,965 38,049,097
16p 35,143,302 160,390 25,336,229 20,462,803
16q 43,883,952 86,933 42,003,582 40,305,188
17p 22,187,133 114,901 21,163,833 20,341,190
17q 56,487,608 82,866 11,472,733 15,591,618
18p 15,400,898 59,951 15,400,898 15,400,898
18q 59,352,257 50,087 33,548,238 26,073,241
19p 26,923,622 82,369 15,825,424 12,506,733
19q 33,888,028 167,408 31,383,029 31,383,029
20p 26,267,569 1,436,102 26,259,569 26,259,569
20q 34,402,734 1,301,134 26,144,333 21,428,992
21p{ 490,223 n/a 490,223 490,223
21q 33,684,323 28,515,322 28,617,429 24,743,931
22p acro arm n/a n/a n/a
22q 35,224,709 23,048,103 23,276,302 16,327,958
Xp 58,465,033 173,718 33,063,353 22,383,515
Xq 93,359,231 277,548 27,718,692 25,766,623
Yp 11,237,315 5,778,849 6,265,435 4,331,076
Yq 15,464,376 1,026,317 10,002,238 8,061,778
All arms 2,879,539,433 82,663 38,509,590 40,970,092
.............................................................................................................................................................................
*Chromosome arm lengths refer to estimated length of euchromatic portions of each arm.
†N50 denotes the contig length x (for a chromosome arm or entire genome) such that half of all
nucleotides reside in contigs of length at least x.
‡‘N50 draft’ reports this number for the draft sequence15.
§The value for the near-complete reference sequence reported here.
kAverage contig length in the near-complete sequence for a randomly chosen nucleotide (or,
equivalently, average length contigs weighted by length).
{Chromosome 21p is an exception to the generalization that the acrocentric arms only contain
heterochromatin—there is a 281-kb contig within chr 21p11.2.
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methodology cannot detect deletions larger than a fosmid, we also
analysed discrepant fosmid links, which could reflect deletions. See
Methods in Supplementary Information.)
We found 242 candidate regions, with suggestive evidence for
deletions (average apparent size ,5 kb). These regions were then
scrutinized by alignment with the recently obtained draft sequence
of the chimpanzee genome (R. H. Waterston, personal communi-
cation). Because the human and chimp genomes align with rela-
tively few large indels (indels .2 kb occur at ,1 per 100 kb), this
comparison should highlight true deletions. The chimpanzee com-
parison supported the presence of deletions in 35% of cases. A
subset of these was then tested by polymerase chain reaction (PCR)
analysis of genomic DNA from multiple individuals. Roughly two-
thirds appear to represent polymorphic deletions in the human
population and one-third represent actual errors in the current
genome sequence. Overall, the results indicate that the current
genome sequence is likely to contain perhaps 50–100 erroneous
deletions (average size ,5 kb), which could be due to assembly
errors or mutations occurring during propagation of large insert
clones. Analysis of a larger collection of fosmids could probably
pinpoint the majority of these errors, allowing them to be corrected.
Assessment of coverage
Tests of coverage were designed to measure the proportion of
the euchromatic genome missing from the current genome
sequence, by assessing the presence of independently sampled
human sequences such as complementary DNA clones and random
genomic clones.
Analysis of cDNAs. We tested for the presence of known cDNA
sequences from public databases (REFSEQ33 and MGC34). The
analysis35 involved 17,458 distinct gene loci spanning 925 Mb of
genomic sequence. The vast majority (99.74%) could be confidently
aligned to the current genome sequence over virtually their com-
plete length with high sequence identity (at a level consistent with
the expected polymorphism rate and the performance of the
alignment program). A few of these (0.5%) showed strong align-
ment to more than one locus. A few others (0.04%) showed
unusually high sequence difference (.2%), but these were nearly
all immunologically related genes (such as major histocompatibility
loci and immunoglobulin-related loci) known to be highly
polymorphic.
We examined the remaining cases (0.28%). The cDNA sequence
appeared to be completely absent in 0.06% of cases and partially
absent, with a contiguous segment missing, in 0.23% of cases. For
Figure 3 Detection of potential insertions or deletions using paired-end fosmid reads. The
top portion shows fosmids along a region of chromosome 10 (centred at nucleotide
46,915,451), mapped by virtue of their paired-end sequences. The difference between
inferred length, calculated from the location of fosmid ends in finished sequence, and
average length for the entire library, is shown to the right of each clone. For each point, the
standard deviation of the local average difference for all spanning fosmids is plotted
below; the threshold of 3.5 standard deviations is indicated by a dotted line. The region
from 45 to 55 kb is inferred to contain a length difference between the fosmids and
finished sequence. Comparison with available chimpanzee sequence further localized the
difference (vertical line). Experimental analysis (PCR from clones used for finished
sequence and the fosmid library, as well as from 24 random humans) confirmed the
difference, and showed that it is due to an insertion/deletion polymorphism of 5.8 kb. The
majority of length differences detected by this analysis appear to represent
polymorphisms, not sequence errors.
Figure 2 Assessment of potential errors by analysis of BAC overlaps. a, Single-base
differences between overlapping finished BAC clones (with $5 kb overlap). The number
of single-base differences in overlaps for clones from the same library and from different
libraries is plotted. The results are consistent with half of the clones from the same library
representing identical underlying DNA sequence with low error rate, and half representing
different haplotypes as expected. b, Insertion/deletion (indel) differences between
overlapping clones. The number of indels per Mb for a given size range is compared for
clones with no single-base mismatches (presumed to be derived from the same haploid
source) and.3 single-base mismatches (presumed to be derived from different haploid
sources). Indels in the former class primarily represent errors in finished sequence; they
occur at ,20-fold lower frequency (inset) than indels in the latter class, which primarily
represent polymorphic differences.
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almost all of completely absent cDNAs, the genomic location of the
gene was known or could be inferred and corresponds to a gap in the
current genome sequence. For the partially absent cDNAs, more
than half of the cases lie adjacent to gaps. The remainder may
represent either errors in the current genome sequence or poly-
morphic deletions; these are being investigated further. Overall, the
proportion of cDNA sequence that is missing from the genome
sequence is only 0.08% of the total. This may underestimate the
proportion of genome missing from the finished sequence, however,
because focused efforts were made to capture genomic sequence
containing missing messenger RNAs.
Analysis of random genomic plasmids. As an additional and
broader test of coverage, we analysed paired end-sequences from
5,000 small-insert (3–4 kb) plasmids generated as part of a human
single nucleotide polymorphism (SNP) discovery project (see
Methods). After excluding heterochromatic repeats and other
artefacts, we found that 99.3% of the reads could be reliably aligned
to the finished sequence. For 0.6% of the reads, neither end could be
aligned; these probably lie in known gaps. For another 0.1% of the
reads, exactly one end could be placed; some fell next to known gaps,
whereas others appear to represent indel differences between the
reference sequence and the source DNA for the plasmid library. The
overall analysis indicates that ,1% of the euchromatic genome is
missing from the finished sequence. Together, the cDNA and
plasmid analyses indicate that the current genome sequence con-
tains more than 99% of the euchromatic portion of the human
genome.
Characterization of remaining gaps
The current genome sequence contains 341 gaps, which could not
Figure 4 Segmental duplications across the genome. a, Segmental duplications and
sequence gaps across the genome. Segmental duplications are indicated below the
chromosomes in blue (length$10 kb and sequence identity$95%). Large duplications
are shown to approximate scale; smaller ones are indicated as ticks. Sequence gaps are
indicated above the chromosomes in red. Large gaps (.300 kb) are shown to
approximate scale; smaller gaps are indicated as ticks with those that are 50 kb or smaller
shown as shorter ticks. Unfinished clones are indicated as black ticks. b, Percentage of
large segmental duplications by chromosome. This count includes both interchromosomal
and intrachromosomal duplications with length$1 kb and sequence identity$90%. The
blue bars show the result of direct analysis of near-complete sequence. The gold bars
show an independent estimate65 using whole-genome shotgun data to correct for
potential mis-assembly of such segmental duplications. The strong agreement suggests
that most segmental duplications are properly represented in near-complete genome
sequence. The discrepancy for chromosome X is probably a result of errors in the
independent estimate, due to limited coverage and diversity of data from this
chromosome15.
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be closed with available techniques. We briefly describe the nature of
these gaps and discuss the prospects for eventual closure. (See
Supplementary Information Notes 2 and 4.)
Heterochromatic regions (33 gaps). The heterochromatic regions
of the human genome were not targeted by the HGP, because their
highly repetitive properties make them largely refractory to current
cloning and sequencing strategies. There are 33 heterochromatic
regions falling into four types. The 24 centromeres (,50 Mb)
consist largely of alpha satellite repeats, of which ,15 types exist;
these monomeric repeats are arranged into higher-order arrays
  
Figure 5 Examples of repeat structure near centromeres and telomeres. a, Repeats in
pericentric regions of chromosomes 7 and 8. The most proximal regions are crowded with
alpha satellite sequences and other centromeric repeats; composition, density and order
may vary considerably between chromosome arms62. Just outside this region, there is
usually a high density of inter- and intra-chromosomal duplication. For details, see text
and refs 39, 40, 66 and 67. b, Sequence organization in human subtelomeric DNA
regions. The terminal repeat tract consists of 2–15 kb of simple repeat sequence
(TTAGGG)n and is indicated by the black arrow at right. Short (50–250 bp) and often
degenerate (TTAGGG) tracts (internal black arrows) are highly enriched (.25-fold) in
subtelomeric DNA relative to elsewhere in the genome. A subtelomeric repeat (Srpt)
region (blue) consists of a mosaic patchwork of segmentally duplicated DNA tracts that
occur in two or more subtelomere regions and range in size from ,10 kb to .300 kb.
TAR1, D4Z4 and beta satellite sequences are frequently associated with Srpt regions.
Proximal to the Srpt region is chromosome-specific genomic DNA, typically with a high GC
content and high gene density. Stretches of segmentally duplicated DNA that occur only
once within subtelomeric regions (tan) are interspersed with 1-copy subtelomeric DNA
(yellow) in a telomere-specific fashion. Overall, segmentally duplicated DNA comprises
approximately 25% of the most telomeric 500 kb of the chromosome, a fivefold
enrichment over the genome-wide average.
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distinct to specific chromosomes, which are tandemly repeated with
slight sequence variations. The three secondary constrictions are
immediately adjacent to the centromere on chromosome arms 1q,
9q and 16q and contain various satellite repeats (beta, gamma,
satellite I, II, III). The five acrocentric chromosome arms 13p, 14p,
15p, 21p and 22p encode the 5S, 18S and 28S ribosomal RNA genes,
which lie on a 43-kb sequence present in ,50 tandem copies on
each arm and are flanked by additional repeats arranged in complex
structures. Finally, there is a single large region on distal Yq
composed primarily of thousands of copies of several repeat
families. The heterochromatic regions all tend to be highly poly-
morphic in length in the human population.
Euchromatic boundary regions (35 gaps). The euchromatic
regions of the human genome are bounded proximally by hetero-
chromatin and distally by a telomere consisting of several kilobases
of the hexamer repeat TTAGGG. We examined the current genome
sequence for evidence of the expected boundaries on the 43
euchromatic arms. (See Supplementary Information Note 4.) At
the proximal ends, 30 of the 43 cases show sequence characteristic of
either heterochromatin or immediately flanking regions (such as
higher-order centromeric repeats, stretches of at least 10 kb of
monomeric alpha satellite repeat or other pericentromeric repeats).
We cannot exclude the possibility that there is additional unique
sequence between this point and the proximal heterochromatin; but
efforts to extend the finished sequence further were unsuccessful. In
the remaining 13 cases, the finished sequence contains no evidence
of heterochromatin-related sequence. At the telomeric ends, 21 of
the 43 cases show continuous sequence extending to the telomeric
repeat. This sequence was typically obtained by isolation and
sequencing of half-YAC clones spanning to the telomere36. An
additional 18 cases are sequence gaps, in which half-YACs reaching
to the telomere were isolated but finished sequence could not be
obtained. The remaining four cases are physical gaps, in which
large-insert clones extending to the telomere could not be obtained.
Euchromatic interior regions (273 gaps). The remaining gaps are
located within the current genome sequence. These consist of 215
physical gaps for which no clones could be isolated, and 58 sequence
gaps for which clones were found but reliable finished sequence
could not be obtained. The physical gaps are greatly enriched in
regions of segmental duplication (Fig. 4a). Roughly half of these
gaps (52%) are flanked by segmental duplications with .90%
sequence identity, although such duplications comprise only
,5.3% of the euchromatic genome (Fig. 4b). Such segmental
duplications are especially frequent in pericentromeric regions,
and gaps are notably more frequent in these regions. The association
of gaps with segmental duplications is examined in detail elsewhere37.
Figure 6 Examples of genes corrected in the near-complete sequence. a, In draft
sequence, exons 6,7 and 8 of hexosaminidase A (HEXA) gene were present on
chromosome 3 in addition to their correct location on chromosome 15. b, In draft
sequence, interleukin 12 beta-2 receptor (IL12RB2) contained an inversion of several
internal exons and a duplication of exon 15. c, In draft sequence, a single-base deletion in
exon 5 of integrin beta-3 precursor (ITGB3) caused a frameshift at amino acid 247. The
terminal exon was also missing.
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The most extreme case occurs near the centromere of chromo-
some 9. The most proximal 5 Mb on 9p and 4 Mb on 9q comprise a
mere 0.3% of the genome, but account for ,12% of the physical
gaps in the euchromatic sequence. These two pericentric regions are
unique in the genome with respect to density of segmental dupli-
cation and the average degree of intrachromosomal sequence
identity (98.7%), and the two regions have many highly similar
sequences in common. The high sequence similarity between the
two regions is likely to be the reason for a polymorphic inversion
of the centric heterochromatin on chromosome 9, present at a
frequency of ,1% in the human population28. Other proximal
regions also show a higher-than-average density of gaps. For
example, the proximal 2 Mb on the remaining 41 euchromatic
arms comprise 2.9% of the genome but harbour 13.3% of the
gaps. Nearly all of these proximal gaps are flanked by segmental
duplications (Fig. 5a). There is also a clustering of such gaps in
subtelomeric regions. The terminal 1 Mb on the 43 euchromatic
arms represents 1.5% of the genome, but contains ,14% of the
total gaps; nearly all of these gaps are also flanked by segmental
duplications (Fig. 5b).
Closing the remaining gaps. Although the euchromatic genome
sequence has reached a much higher degree of completion than had
been anticipated, it still remains incomplete with ,1% of the
euchromatin residing in 308 gaps. These represent regions that
could not be reliably mapped, cloned and sequenced with current
methods. Rather than applying further brute force, it is now time to
develop focused strategies to resolve the regions.
The remaining euchromatic gaps probably reflect two major
issues. The first pertains to regions harbouring segmentally dupli-
cated sequence. Such regions are challenging to map because it can
be extremely difficult to discern whether two clones with small
sequence differences represent different loci or different alleles at a
single locus. This challenge was eventually resolved for chromosome
Y (ref. 23) (which is especially rich in segmental duplication) by
exploiting the fact that the chromosome is haploid in males. By
using DNA from a single haploid source, it was possible to rely on
differences at only a handful of nucleotides to distinguish repeated
sequences. This approach could be applied to the rest of the genome
by using appropriate haploid sources, such as a hydatidiform mole
or monochromosomal hybrids. (In both instances, use of parental
controls to guard against being misled by somatic rearrangements
would be well advised.) It may be useful to test these approaches on
individual chromosomes. The second issue is that some gaps are
likely to correspond to regions that cannot be efficiently propagated
in current large-insert vectors and hosts. It may be useful to test new
kinds of large-insert libraries for clones containing unique
sequences not contained in the current human genome sequence
(perhaps seeded by probes derived from random small-insert
genomic plasmids, as discussed above). In addition, genome com-
pletion may benefit from long-range mapping techniques such as
optical mapping38, which may provide independent information
about difficult regions.
Completing the euchromatic sequence is an important goal, but
is clearly now a research effort rather than a high-throughput
project. Sequencing the human heterochromatin poses an even
greater challenge. The current human sequence penetrates only the
periphery of the heterochromatin—for example, the pericentric
regions on a few chromosome arms39,40. This progress has required
concerted efforts with specialized mapping techniques and pains-
taking assembly. The fundamental issue is that current shotgun
Table 4 Human paralogous genes
Chromosome Cluster size in human genome Minimum size in ancestral genome Genes involved in recent duplications Gene family
...................................................................................................................................................................................................................................................................................................................................................................
2 30 8 26 Immunoglobulin K chain V
11 64 50 23 Olfactory receptor
19 23 5 19 KRAB zinc-finger protein
14 21 9 15 Immunoglobulin heavy chain
9 16 4 13 Interferon a
1 34 25 13 Olfactory receptor
19 18 9 13 Leukocyte and NK cell immunoglobulin-like receptors
22 20 11 12 Immunoglobulin l chain V-region
1 13 3 11 PRAME/MAPE family (cancer/germ line antigen)
16 11 2 11 Immunoglobulin heavy chain
19 10 1 10 Pregnancy-specific b-1-glycoprotein
11 59 54 10 Olfactory receptor
X 9 1 9 Hypothetical gene LOC255313 expressed in testis
17 13 9 8 Olfactory receptor
4 9 3 7 UDP-glucuronosyltransferase; steroid metabolism
12 14 8 7 Taste receptor, type 2
19 16 10 7 FDZF2-like KRAB zinc-finger protein
X 7 1 7 SSX-like KRAB zinc-finger protein (CT antigens)
X 8 2 7 MAGE (CT antigens)
Y 7 1 7 Testis-specific Y-encoded (TSPY) protein
4 9 5 7 CXCL1/MIP2-like small chemokines
7 6 1 6 Postmeiotic segregation increased-2 (DNA mismatch repair)
8 6 1 6 FLJ00326 hypothetical protein
11 6 1 6 TRIM48, testis-specific RING finger protein
16 6 1 6 Tumour protein p53-inducible gene, TP53TG3
Y 6 1 6 Testis-specific Y-encoded (TSPY) protein
6 7 3 6 Butyrophilin subfamilies 2 and 3
11 23 19 6 Olfactory receptor
19 18 14 6 Gonadotropin-inducible transcription repressor-2-like
7 5 1 5 Williams Beuren syndrome chromosome region 19 protein
8 5 1 5 Exonuclease GOR
11 5 1 5 Yeast Ssu72p-like protein
14 6 2 5 Immunoglobulin a, d, g chains
16 5 1 5 Metallothionein 2A-like
17 5 1 5 Growth hormone gene cluster
19 5 1 5 Testis-specific transcriptional repressor
19 5 1 5 Choriogonadotropin beta (placental hormones)
X 6 2 5 GAGE (CT antigens)
X 5 1 5 XAGE (CT antigens)
X 5 1 5 Sarcoma antigen SAGE (CT antigens)
X 5 1 5 SPAN-X; sperm protein (CT antigens)
...................................................................................................................................................................................................................................................................................................................................................................
The above table includes clusters of human paralogous genes having at least five genes involved in recent gene duplications. Recent is defined as divergenceKS # 0.3 (see text), corresponding roughly to
the divergence of primate and rodent lineage. Ancestral cluster size is the minimum required to account for existing clusters in human, assuming no gene losses in the human-specific lineage.
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strategies are poorly suited to assembling large, highly repetitive
regions. The hierarchical shotgun strategy faces the challenge of
accurate assembly of individual BACs and accurate overlap of BAC
clones, with the underlying data consisting of nearly identical
sequence; the whole-genome shotgun strategy compounds these
problems. Conceivably, the hierarchical strategy could be adapted as
was done for repetitive regions of chromosome Y. Approaches
might include the use of the following: haploid DNA sources to
restrict the problem to a single haplotype; single chromosome
sources to avoid confusion among related centromeres on different
chromosomes; sheared BAC libraries to avoid biases caused by the
unusual distribution of restriction sites within the repeat sequences;
assembly based on rare base differences that distinguish near-
identical repeats; cloning vectors that minimize rearrangements;
and subclone libraries of varying insert lengths. Such an approach
will also require ensuring accurate recovery and stability of hetero-
chromatic regions in large-insert clones. Even so, the path is likely to
be arduous and expensive to obtain regions of uncertain infor-
mation content. Alternatively, it may be possible to develop new
approaches. These might include methods to obtain much longer
effective read lengths, directed reads from known locations and
long-range mapping information about the location of rare base
differences among repeat copies (such as optical mapping38 or
padlock probes41).
Examples of utility of near-complete sequence
The present genome sequence enables far more precise analyses of
the human genome, especially those that depend sensitively on high
accuracy and near-completeness. Rather than revisit all of the
analyses in our initial analysis of the human genome, we have
chosen four examples that illustrate the utility of the current near-
complete sequence.
Segmental duplications
The human genome is notable for its high proportion of recent
segmental duplications. They are of great medical interest because
their unusual structure often predisposes them to deletion or
rearrangement with consequent phenotypic effects; prominent
examples include the Williams syndrome region (7q), Charcot–
Marie–Tooth region (17p), DiGeorge syndrome region (22q) and
the AZF-C region (Y)42. Some regions of segmental duplication
have also recently been shown to be evolutionary nurseries in which
coding sequences are undergoing strong positive selection43. Accu-
rate analysis of segmental duplications was previously impossible
because the draft sequence also contained a high degree of artefac-
tual duplication. This difficulty was recognized at the time and the
approximate proportion of true and artefactual duplication was
inferred indirectly. With near-complete sequence, the artefacts are
now largely eliminated and true segmental duplications can be
reliably studied.
On the basis of the current sequence, segmental duplications
cover ,5.3% of the euchromatic genome. (Here, segmental dupli-
cations are counted as regions that are not transposable element
copies, are $1 kb in length and have sequence identity $90%; this
corresponds to duplication within the past ,40 million years.) The
proportion of segmental duplication and the degree of sequence
identity are clearly substantially higher in the human genome than
in the mouse44 or rat45 genomes (although precise figures for
the rodent genomes must await finished sequence). The use of
large insert clones, representing a single haplotype, was critical in
resolving these regions. The distribution of segmental duplication
varies widely across chromosomes, as does the proportion of
intrachromosomal versus interchromosomal duplications15
(Fig 4b). The most extreme case is chromosome Y, which carries
segmental duplication along .25% of its total length and includes
blocks as large as ,1.45 Mb with sequence identity of ,99.97%
(ref. 23). In addition, many pericentromeric and subtelomeric
regions are rich in dispersed segmental duplications (Fig. 5),
apparently resulting from a steady bombardment of insertional
translocations46. Although most regions of segmental duplication
have now been sequenced, ,10% of them lie in the remaining gaps
in the current sequence and will require further work to elucidate, as
discussed above.
Protein-coding genes
A central goal of genome analysis is the comprehensive identifi-
cation of all human genes. This task remains challenging, but is
greatly aided by the near-complete sequence together with other
improved resources (such as expanded cDNA collections, genome
sequence from other organisms and better computational
methods). The current version of the human gene catalogue
(Ensembl 34d) contains 22,287 gene loci (with a total of 34,214
transcripts, corresponding to 1.54 transcripts per locus), consisting
of 19,438 known genes and 2,188 predicted genes. These gene loci
have a total of 231,667 exons, with ,10.4 exons per locus and ,9.1
exons per transcript. The total length covered by the coding exons is
,34 Mb or ,1.2% of the euchromatic genome; the untranslated
regions of the transcripts are estimated to cover another ,21 Mb or
,0.7% of the euchromatic genome.
Comparison of the initial and current gene catalogues highlights
the substantial improvement. Many of the earlier gene models were
erroneous due to defects in the draft sequence. Examples resulting
from a duplication, inversion and premature stop codon are shown
in Fig. 6. The improvement can be quantified by mapping the
current gene models onto the draft sequence, to determine whether
they could have been accurately identified. Of the transcripts in the
current gene catalogue, 58% have at least one error when mapped
onto the draft sequence. For 39% of transcripts, there is at least one
Figure 7 Distribution of K S for recent gene duplications. K S, the number of synonymous
substitutions per synonymous site, was estimated for each gene from alignment with its
most closely related human paralogue. This provides an indication of evolutionary time
since divergence.
Table 5 Categories of recently arising human pseudogenes
Inactivating mutations in the reference sequence
1 mutation .1 mutation Total
.............................................................................................................................................................................
Chimp pseudogene 8 19 27
Human pseudogene 5 0 5
Human allelic null 1 0 1
Sequence error 1 0 1
Total 15 19 34
.............................................................................................................................................................................
Potential pseudogenes were identified by searching orthologous segments in human, mouse and
rat (see text). Frameshifts and nonsense mutations in putative human pseudogenes were
experimentally investigated by resequencing the original human BAC clones (to look for sequence
errors), as well as sequencing 24 unrelated individuals (to assess whether apparent mutation is a
polymorphism) and chimpanzee (to assess timing of loss of function).
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exon that is absent or incorrectly ordered due to defects in the
draft. For the remaining 19% of transcripts, the exons are all
present and correctly ordered, but there are one or more nucleotide
errors.
Automated gene annotation has now been complemented by
manual annotation of most chromosomes, based on a careful review
of gene structure and examination of expressed-sequence-tag (EST)
and transcript evidence. Such analysis has been completed for 18
chromosomes (2, 4, 5, 6, 7, 8, 9, 10, 13, 14, 15, 17, 18, 19, 20, 21, 22, X
and Y; refs 17, 20–30 and http://vega.sanger.ac.uk/Homo_sapiens/),
with the remainder in the press or in preparation) comprising
1.7 Gb of the euchromatic genome. Although this annotation has
further improved the quality of the gene models47 (by dealing with
special cases and unusual features not yet handled in the automated
programs, and resolving instances of conflicting experimental data),
it has not significantly affected the total gene count for these
chromosomes.
On the basis of available evidence, our best estimate is that the
total number of protein-coding genes is in the range 20,000–25,000.
The lower bound seems secure, based on the number of currently
known genes (19,599). The upper bound is based on estimates of the
number of additional genes. Despite intense automated and manual
analysis using cDNA, EST and cross-species homology, only 2,188
gene predictions have been added to the known set. This predicted
set is likely to represent substantially fewer than 2,000 true genes,
owing to fragmentation and false predictions arising from pseudo-
genes. For example, the predictions tend to have fewer exons per
transcript than known genes (,4.7 versus ,9.7) and to encode
shorter open reading frames (,847 versus,1,487 amino acids). On
the other hand, the set is likely to be incomplete because some
protein-coding genes have surely continued to escape detection.
The most problematic cases would be genes that have very short
open reading frames (,100 amino acids), consist of single exons or
evolve very rapidly. Even if we assume that such genes comprise 10%
of the total (which seems a generous overestimate, given our current
understanding of the human and other genomes48–50), the total gene
count would remain below 25,000. The range of 20,000–25,000 is
also consistent with recent estimates (J. Weissenbach, unpublished)
of the number of protein-coding genes based on cross-species
homology (using the Exofish method51).
In our initial analysis of the draft sequence15, we estimated the
count of human protein-coding genes at roughly 30,000. The
estimate was derived as follows. We used computational analysis
to generate an initial gene catalogue with ,32,000 entries, consist-
ing of ,15,000 known genes and ,17,000 gene predictions. We
estimated that the catalogue actually corresponded to ,24,500
actual genes, based on estimates of the rate of various types of
errors such as fragmentation and false positive predictions (due
largely to limitations of the draft sequence, such as imperfect
recognition of pseudogenes and unknown order and orientation).
We then adjusted the estimate to account for the proportion of
genes estimated to be absent from the initial catalogue due to
incomplete coverage of the genome and imperfect computational
methods, resulting in a figure of ,31,000 genes.
With the current high-quality sequence, it is now possible to
revisit this earlier analysis. We directly compared the previous gene
models with the current gene models, to determine whether our
previous estimates of the various error rates were correct. It is clear
that the main reason for the earlier overestimate is that the
fragmentation rate was substantially underestimated. The fragmen-
tation rate is defined as the average number of the previous gene
models that map to the same true gene; we assessed it by mapping to
the current gene catalogue. The fragmentation rates for ‘known’ and
‘predicted’ genes were estimated in our earlier paper15 at ,1.0 and
,1.4, whereas our current analysis indicates that they should have
been ,1.3 and ,1.7. This correction alone would bring our
previous estimate to ,24,000. Small differences in the estimated
rate of false positive and negative predictions account for the
remainder of the discrepancy.
It should be emphasized that the count above refers to the count
of protein-coding genes. It does not include known non-coding
RNAs, such as transfer RNAs, ribosomal RNAs, small nucleolar
RNAs (snoRNAs) and microRNAs52–54. In addition, there is evi-
dence that the human genome gives rise to many additional RNA
transcripts55. It is unclear whether most such transcripts have
specific biological functions or reflect reproducible transcriptional
noise; few contain substantial open-reading frames and thus they are
unlikely to encode proteins. There is a need for reliable experimental
and computational methods for comprehensive identification of
non-coding RNAs.
Finally, the near-complete sequence makes it possible to under-
take systematic searches for pseudogenes. Automated annotation of
chromosomes has focused primarily on identifying large pseudo-
genes of more recent origin. Recent published studies have used
more sensitive methods to detect smaller and older pseudogenes
and have already identified ,20,000 processed and unprocessed
pseudogenes56. This is surely still an underestimate, because such
analysis will miss pseudogenes that are extremely old or that contain
primarily untranslated regions. The total number of pseudogenes is
thus likely to exceed the total number of functional genes. A
particular type of pseudogene (recently arising non-processed
pseudogenes) is discussed in more detail below.
Gene birth in the human lineage
The birth of new genes is of interest because it provides raw material
for adaptive evolution, with extra copies of genes able to undergo
functional divergence in response to positive selection. The quality
and completeness of the current sequence make it possible to study
this question; such analysis would have been unreliable with
the earlier draft sequence, because the extensive artefactual local
duplication would have given rise to many false positives.
We searched for clusters of nearby homologous genes, indicative
of local gene duplication. The divergence between such genes was
assessed at sites likely to be selectively neutral, by measuring the
estimated substitution rate per synonymous site (KS). We looked
for nearby human gene pairs differing from one another by
KS , 0.30, implying that each differs from the common ancestral
source gene by an average KS , 0.15. This threshold corresponds
roughly to duplications arising after divergence from the rodent
lineage, either by recent gene duplication or perhaps recent gene
conversion of older duplications (see Methods in Supplementary
Information). A total of 1,183 genes exhibit such divergence from a
neighbouring gene (see Methods in Supplementary Information).
These genes often fall within larger clusters of paralogous genes
including genes with greater divergence and reflecting older dupli-
cations. These clusters contain ,3,300 genes, and those having at
least five genes involved in recent duplication events are shown in
Table 4. Analysis of phylogenetic trees containing the related human
and mouse genes confirms that the genes are more closely related
within each species than between the two species in nearly all cases
(97%), as would be expected for genes arising by duplication after
the divergence of the human and rodent lineages.
The recent duplications are enriched in genes with immune and
olfactory function, as well as those likely to be involved in repro-
ductive functions. For example, the gene families encoding the
pregnancy-specific beta-1-glycoprotein and choriogonadotropin
beta proteins may be involved in the extended gestational period
in the human lineage; the latter family is known to have expanded
recently within the catarrhine primate lineage57. Another example is
the family of cancer/testis (CT) antigen genes, which are normally
expressed in the testis and are highly expressed in carcinomas58.
The distribution of KS values (Fig. 7) for recent duplications
shows a striking excess of genes with strong similarity (KS # 0.015),
corresponding to recent events occurring ,3–4 million years ago.
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There are several possible explanations for this peak. First, it may
reflect a true explosion in the rate of gene duplication in the primate
lineage. (The primate lineage does show an increase in the rate of
dispersed segmental duplication, although it is less extreme; the rate
of local duplication will need to be carefully evaluated in compara-
tive studies.) Second, it may partly reflect on the ongoing process of
gene conversion of older gene duplication events. However, we offer
a third explanation: the peak primarily reflects the transient of
duplicated genes that are too young relative to the characteristic
time of deletion. If so, most of these new genes are destined to be
culled due to lack of functional benefit. In contrast to the first
explanation, this would predict that a similar peak would be seen in
most mammals.
Gene death in the human lineage
Gene death is another phenomenon that sheds light on lineage-
specific evolution, but which was difficult to analyse with the earlier
draft sequence. To study gene death, we scanned the genome
sequence for recently arising non-processed pseudogenes—that is,
nearly intact human genes that appear to have recently acquired an
inactivating mutation. Specifically, we examined genomic intervals
bounded at each end by two consecutive genes, with each belonging
to a 1:1:1 orthology triplet in the human, mouse and rat genomes
and the interval containing at most 50 genes (see Methods in
Supplementary Information). We then examined the Ensembl gene
predictions in the corresponding intervals of the three genomes and
identified instances in which the mouse and rat genomes contained
1:1 orthologues, but the human genome appeared to contain no
predicted orthologous gene. In each instance, the rodent genes were
aligned to the corresponding human genomic interval to look for
clear evidence of a human pseudogene—that is, a highly similar
sequence containing one or more inactivating mutations in its
genomic sequence (see Methods in Supplementary Information).
We also required that the inactivating mutation was present in any
human mRNA sequences corresponding to the locus. (This analysis
excludes many older pseudogenes that do not show sufficient
similarity to the rodent homologues because they have substantially
degenerated.)
A total of 37 candidate pseudogenes were identified, with
an average of 0.8 premature stop codons and 1.6 frameshifts
(Supplementary Table 1). (Similar analyses performed on the
draft sequence yielded a much larger list, including many apparent
inactivating mutations that were errors and were corrected in the
current sequence.) We carefully examined these candidates to
confirm that they did not reflect errors in the current genome
sequence (by resequencing or examination of an independently
finished clone) and to determine their evolutionary origin (by re-
sequencing in a panel of 24 diverse humans and comparison with a
draft sequence of the chimpanzee genome). Complete experimental
data could be obtained for 34 cases. The identification of a
pseudogene was confirmed in 33 of the 34 cases; one case was due
to an error in the current sequence (Table 5). The 19 pseudogenes
with two or more inactivating mutations were all found to be
pseudogenes in chimpanzee as well. The 14 pseudogenes with
exactly one inactivating mutation fell into the following three
classes: eight pseudogenes shared with chimpanzee; five pseudo-
genes fixed in the human population but functional genes in the
chimpanzee; and one pseudogene that is a segregating polymorph-
ism in the human population. (In 20 cases, the inactivating
mutation occurs in the final or only exon. Although this could in
principle be compatible with a functional gene, the truncation
removes a functionally important domain in all but one case.)
Of the 32 pseudogenes fixed in the human population, 10 are
derived from olfactory receptors. Olfactory receptors thus occur
prominently in both birth and death analyses, indicating a dynamic
expansion and contraction of this large gene family; the net effect
has been an overall significant decrease in the number of functional
olfactory receptors in humans compared with rodents59,60. The
remaining 22 recent pseudogenes include a wide variety, such as
genes homologous to a cationic amino-acid transporter, a serine-
threonine kinase, a calreticulin, a putative G-protein coupled
receptor and a cystatin.
Discussion
The Human Genome Project marked a new approach in biomedical
research, one in which the scientific community came together to
characterize systematically a large domain of important biological
knowledge. Because the precise scientific plan and the feasible
degree of accuracy and completeness were unclear at the outset,
the sequencing of the human genome proceeded in phases: a
preliminary phase that developed and refined key approaches; a
draft phase that yielded ,90% of the information (albeit in
imperfect form); and a finishing phase reported here that yielded
,99% in high-quality form. Notably, the finishing phase required
roughly equal resources of time and expense as the draft phase.
The euchromatic portion of the human genome is still not
complete, with ,1% still to be determined. The issue is no longer
scale, but rather the need for new approaches to understand and
resolve these recalcitrant segments. Continuing efforts should be
devoted towards the eventual goal of complete closure. Nonetheless,
the euchromatic human genome can now be regarded as effectively
known. The accuracy and completeness of the current near-
complete human genome sequence has important consequences
for biomedical research. It allows systematic searches for the causes
of disease—for example, to find all key heritable factors predisposing
to diabetes or somatic mutations underlying breast cancer—with
confidence that little can escape detection. It facilitates experimental
tools to recognize cellular components—for example, detectors for
mRNAs based on specific oligonucleotide probes or mass-spectro-
metric identification of proteins based on specific peptide
sequences—with confidence that these features provide a unique
signature. It allows sophisticated computational analyses—for
example, to study genome structure and evolution—with confi-
dence that subtle results will not be swamped or swayed by noisy
data. At a practical level, it eliminates tedious confirmatory work by
researchers, who can now rely on highly accurate information. At a
conceptual level, the near-complete picture makes it reasonable
for the first time to contemplate systems approaches to cellular
circuitry, without fear that major components are missing.
The HGP provides an essential foundation for the sequencing
and analysis of additional large genomes. With the experience
gained from the human genome, it has already become scientifically
and economically feasible to produce draft genome sequence from
many vertebrates, which will be a crucial tool for identifying the
functional elements in the human genome through comparative
analysis. Ultimately, we believe that such projects should aim higher
to produce genome sequence with even greater accuracy and
completeness. This will require digesting the diverse experience
from the finishing phase of human sequencing and selecting a
subset of techniques that can be most efficiently streamlined and
scaled up to improve accuracy and completeness of genome
sequence. A good example is the systematic closure of gaps by
primer-directed walking on fosmid templates covering each gap,
which may be able to close the vast majority of gaps in a draft
sequence in an automated fashion.
More generally, the HGP demonstrates the tremendous potential
value of coordinated projects to create community resources to
propel biomedical research. Key challenges that lie ahead61 include:
(1) systematic identification of all genetic polymorphisms carried in
the human population, to facilitate the study of their association
with disease; this will require comprehensive study of hundreds to
thousands of human genomes. (2) Systematic identification of all
functional elements in the human genome, including genes, pro-
teins, regulatory controls and structure elements; this will require
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comparative analysis with many additional mammalian genomes
and systematic application of diverse experimental techniques. (3)
Systematic identification of all the ‘modules’ in which genes and
proteins function together; this will require comprehensive study
and improved interpretation of expression, localization and inter-
action in a temporal and spatial context. Absolute completeness will
be elusive but, as with the HGP, obtaining the substantial majority
of the information will greatly accelerate the pace of biomedical
research in thousands of laboratories. A
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